Mark Hensley Promoted to Chief Commercial Officer of Veloxis Pharmaceuticals |
January 03, 2019 | January 2019 Bond Updates |
COPENHAGEN, Denmark, Jan. 2, 2019 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (NASDAQ: VELO) today announces the promotion of Mark Hensley to Chief Commercial Officer. Mr. Hensley has served as the Vice-President of Sales for Veloxis Pharmaceuticals, Inc., since May 2017, where he has... |
View more at: https://www.prnewswire.com:443/news-releases/mark-hensley-promoted-to-chief-commercial-officer-of-veloxis-pharmaceuticals-300772181.html |
Related News |
|